VU Research Portal
Towards clinical implementation of personalised PRRT in patients with
neuroendocrine tumours
Huizing, D.M.V.
2021
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Huizing, D. M. V. (2021). Towards clinical implementation of personalised PRRT in patients with neuroendocrine
tumours: Optimisation of nuclear imaging techniques, dosimetry and response evaluation.
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Contents
Chapter 1 Introduction and outline 7
Part I - Quantitative nuclear imaging and post-therapy dosimetry in NETs Chapter 2 Multicentre quantitative 68Ga PET/CT performance
harmonisation
23
Chapter 3 177Lutetium SPECT/CT: evaluation of collimator, photopeak
and scatter correction
39
Chapter 4 Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature review
53
Chapter 5 A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy
83
Part II - Clinical outcome after PRRT
Chapter 6 Parameters to predict progression free and overall survival after peptide receptor radionuclide therapy: a multivariate analysis in 782 patients
113
Chapter 7 Haematotoxicity during PRRT: baseline parameters differences and effect on patient’s management
139
Chapter 8 Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy
157
Chapter 9 Discussion and future perspectives 183
Appendices Summary Samenvatting Affiliations List of publications Dankwoord Curriculum vitae 197 203 211 217 221 229
